Answers are grounded in this paper and cite their sources.
Introduction. The cardiorenometabolic continuum represents the current concept of the patient’s health status, from the action of risk factors to clinical manifestation in the form of cardiovascular, renal and metabolic disorders. Elder patients require special attention, given the presence of comorbidity (including cerebrovascular diseases), gerontological syndromes, and polypharmacy, which leads to unfavorable prognosis. The study of cardiorenometabolic continuum and cerebrovascular pathology interactions becomes especially relevant to optimizing the prevention of, timely diagnosis of, and patient-oriented approaches to the management of comorbid patients. Aim of the study was to discuss the cardiorenometabolic continuum problem relevance in patients with cerebrovascular diseases. Materials and Methods. When analyzing sources of domestic and foreign literature, keywords were used, such as “cardiorenometabolic continuum,” “renal continuum,” “cerebrovascular diseases,” “kidney-brain axis,” “acute cerebrovascular accidents,” and “metabolic syndrome.” The “Scientific electronic library eLIBRARY.RU” search engine was used to analyze Russian- language sources of literature, while PubMed and Scopus databases were used to search for English-language sources. Results and Discussion. Cardiorenometabolic continuum determines the ongoing dynamics of changes occurring in the body. In turn, cerebrovascular diseases are considered as an important aspect of the cardiovascular component in forming the cardiorenometabolic continuum. Renal disorder is one of the components of the cardiorenometabolic continuum and of special interest due to its insufficient and untimely diagnoses in comorbid patients. In recent years, the problem of kidney-brain interactions has been actively discussed in the scientific community, and therefore, many epidemiological studies appear. Kidneys and brain have common anatomical and functional characteristics, making them vulnerable to similar vascular risk factors, which has led to developing the kidney-brain axis concept. A special feature in determining the strategy in patients with cerebrovascular pathology and impaired renal function is their elder and senile age that requires a distinction between the concepts of temporal ageing and of pathology, as well as the patient-oriented approach. Conclusions. Managing comorbid patients with cerebrovascular diseases with regard to cardiorenometabolic continuum involves the management of risk factors; monitoring of persons having one of the continuum components; therapy aimed at cardio- and nephroprotection; improved control of concomitant diseases; and the achievement of target levels of blood pressure and lipid and glycemic profile in accordance with the categories of high and very high cardiovascular risks.
No takes yet. Share an insight, caveat, or question.
MARIA M. REBROVSKAYA (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: